Fertility preservation in women with cancer represents a major medical challenge at the intersection of oncological and reproductive concerns.
With therapeutic advancements, the survival rates of cancer patients have significantly improved, offering the possibility of motherhood.
Currently, there is a lack of data on the return of cryopreserved oocytes/embryos and pregnancy outcomes following cancer treatment.
